Molecular mechanisms of TACE refractoriness: Directions for improvement of the TACE procedure.

Chao Qu, Jiahao Li, Ruipeng Zheng, Jiarui Li, Yingnan Liu

Journal: Life sciences 2024;342():122540

PMID: 38428568

Free Full Text on Elsevier Science View on PubMed

Abstract

Transcatheter arterial chemoembolisation (TACE) is the standard of care for intermediate-stage hepatocellular carcinoma and selected patients with advanced hepatocellular carcinoma. However, TACE does not achieve a satisfactory objective response rate, and the concept of TACE refractoriness has been proposed to identify patients who do not fully benefit from TACE. Moreover, repeated TACE is necessary to obtain an optimal and sustained anti-tumour response, which may damage the patient's liver function. Therefore, studies have recently been performed to improve the effectiveness of TACE. In this review, we summarise the detailed molecular mechanisms associated with TACE responsiveness and relapse after this treatment to provide more effective targets for adjuvant therapy while helping to improve TACE regimens.

Address: Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China; The Public Laboratory Platform of the First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.; Department of Radiology, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.; Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China.; Department of Interventional Therapy, The First Hospital of Jilin University, Changchun, Jilin Province, People's Republic of China. Electronic address: [email protected].

DOI: 10.1016/j.lfs.2024.122540